Literature DB >> 9247287

Expression of matrilysin in vascular endothelial cells adjacent to matrilysin-producing tumors.

Y Nagashima1, S Hasegawa, N Koshikawa, A Taki, Y Ichikawa, H Kitamura, K Misugi, Y Kihira, Y Matuo, H Yasumitsu, K Miyazaki.   

Abstract

Matrilysin is believed to play important roles in tumor progression and metastasis. In the present study, we analyzed matrilysin-producing cells in various human cancer tissues by immunohistochemistry and in situ hybridization. Tumor cells in colorectal carcinomas, pancreatic carcinomas, transitional-cell carcinomas of the kidney and small-cell lung carcinomas were frequently positive for matrilysin. In addition, we found that endothelial cells of arterioles and venules adjacent to matrilysin-positive tumors expressed matrilysin mRNA and protein. The endothelial cells adjacent to matrilysin-negative tumors and those in normal tissues were negative for matrilysin. Furthermore, analyses by casein zymography, Western blotting and RT-PCR showed that matrilysin was weakly expressed by cultured human umbilical vein endothelial cells. Our results suggest that the expression of matrilysin in vascular endothelial cells and in tumor cells may be regulated by common soluble factors, and that endothelial cell-derived matrilysin may contribute to tumor angiogenesis and tumor metastasis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9247287     DOI: 10.1002/(sici)1097-0215(19970729)72:3<441::aid-ijc11>3.0.co;2-f

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  9 in total

1.  Matrix metalloproteinases in gastrointestinal cancer.

Authors:  P D Brown
Journal:  Gut       Date:  1998-08       Impact factor: 23.059

Review 2.  The role of matrix metalloproteinase genes in glioma invasion: co-dependent and interactive proteolysis.

Authors:  T E VanMeter; H K Rooprai; M M Kibble; H L Fillmore; W C Broaddus; G J Pilkington
Journal:  J Neurooncol       Date:  2001-06       Impact factor: 4.130

3.  Elevated matrix metalloprotease and angiostatin levels in integrin alpha 1 knockout mice cause reduced tumor vascularization.

Authors:  A Pozzi; P E Moberg; L A Miles; S Wagner; P Soloway; H A Gardner
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-29       Impact factor: 11.205

4.  Osteoactivin regulates head and neck squamous cell carcinoma invasion by modulating matrix metalloproteases.

Authors:  Oneida A Arosarena; Eric W Barr; Ryan Thorpe; Hilary Yankey; Joseph T Tarr; Fayez F Safadi
Journal:  J Cell Physiol       Date:  2017-04-25       Impact factor: 6.384

5.  Matrix metalloproteinase-7 induces homotypic tumor cell aggregation via proteolytic cleavage of the membrane-bound Kunitz-type inhibitor HAI-1.

Authors:  Tomohiro Ishikawa; Yayoi Kimura; Hisashi Hirano; Shouichi Higashi
Journal:  J Biol Chem       Date:  2017-10-18       Impact factor: 5.157

6.  Distinct profiles of epigenetic evolution between colorectal cancers with and without metastasis.

Authors:  Hai-Xing Ju; Byonggu An; Yasuyuki Okamoto; Keiko Shinjo; Yukihide Kanemitsu; Koji Komori; Takashi Hirai; Yasuhiro Shimizu; Tsuyoshi Sano; Akira Sawaki; Masahiro Tajika; Kenji Yamao; Makiko Fujii; Hideki Murakami; Hirotaka Osada; Hidemi Ito; Ichiro Takeuchi; Yoshitaka Sekido; Yutaka Kondo
Journal:  Am J Pathol       Date:  2011-03-04       Impact factor: 4.307

7.  Cholesterol sulfate alters substrate preference of matrix metalloproteinase-7 and promotes degradations of pericellular laminin-332 and fibronectin.

Authors:  Kazuhiro Yamamoto; Kaoru Miyazaki; Shouichi Higashi
Journal:  J Biol Chem       Date:  2010-07-06       Impact factor: 5.157

8.  Optical imaging of matrix metalloproteinase-7 activity in vivo using a proteolytic nanobeacon.

Authors:  Randy L Scherer; Michael N VanSaun; J Oliver McIntyre; Lynn M Matrisian
Journal:  Mol Imaging       Date:  2008 May-Jun       Impact factor: 4.488

9.  Invasion and MMP expression profile in desmoid tumours.

Authors:  H Denys; O De Wever; B Nusgens; Y Kong; R Sciot; A-T Le; K Van Dam; A Jadidizadeh; S Tejpar; M Mareel; B Alman; J-J Cassiman
Journal:  Br J Cancer       Date:  2004-04-05       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.